Search company, investor...
Delmic company logo

Delmic

delmic.com

Founded Year

2010

Stage

Seed | Alive

Total Raised

$2.74M

Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

+10 points in the past 30 days

About Delmic

Delmic creates high-performance correlative light and electron microscopy and cathodoluminescence solutions for the life sciences and materials science.

Headquarters Location

Kanaalweg 4

Delft, 2628,

Netherlands

+31 (0)15 744 01 58

Delmic's Product Videos

Compete with Delmic?

Ensure that your company and products are accurately represented on our platform.

Delmic's Products & Differentiators

    METEOR

    Integrated fluorescence system for (cryo) FIB/SEM, creating a better targeting solution for proteins in cryogenic samples

Delmic Patents

Delmic has filed 8 patents.

The 3 most popular patent topics include:

  • Accelerator physics
  • Electron microscopy
  • Mass spectrometry
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/20/2015

5/12/2020

Microscopy, Electron microscopy, Microscopes, Spectroscopy, Electron beam

Grant

Application Date

7/20/2015

Grant Date

5/12/2020

Title

Related Topics

Microscopy, Electron microscopy, Microscopes, Spectroscopy, Electron beam

Status

Grant

Latest Delmic News

IQblog / COL met Sander den Hoedt, CEO van DELMIC

Jun 23, 2020

IQblog / COL met Sander den Hoedt, CEO van DELMIC Vertel eens over jullie bedrijf DELMIC is gevestigd in Delft en maakt geïntegreerde licht- en elektronenmicroscopieoplossingen voor onderzoek. De producten worden gebruikt voor materiaalonderzoek, vooral op het gebied van III-V materialen; LEDs, zonnepanelen en biologisch onderzoek, vooral op het gebied van kanker, neurologie en diabetes. En wie ben jij? Wat was de eerst merkbare impact van COVID-19? Wij merkten de impact van COVID-19 vrij vroeg omdat we ook vrij veel zaken doen in China. Daar ging eind vorig jaar en begin dit jaar echt alles op slot, waardoor we merkten dat beloofde deals niet meer doorgingen en onze leveringen aan klanten niet meer mogelijk waren. Kort daarop merkten we ook de problemen in Italië waar we dit jaar een aantal deals en leveringen hadden lopen. Vanaf halverwege maart was het onmogelijk om nog systemen uit te leveren en werden vrijwel alle orders ook uitgesteld. Waarom hebben jullie gekozen voor COL? De COL regeling maakt het mogelijk om de (hopelijk) korte periode dat echt alles op slot is te overleven. Zonder leveringen heeft het bedrijf bijna geen cashflow, dus we zochten een oplossing om dit te overbruggen. Omdat de COL specifiek gericht is op het soort bedrijf dat DELMIC is (high-tech scale-up) was dit een ideaal instrument. Tot op zekere hoogte biedt de NOW ook oplossingen voor de salarissen. Nadeel van de NOW is echter dat de maatstaf de daling in de omzet ten opzichte van vorig jaar is. Omdat wij aan het groeien zijn dekt de NOW dus niet de volledige terugval tussen prognose – waarop het personeelsbestand is ingericht – en de realiteit met COVID-19. De COL was dus een betere oplossing voor ons. Waar wordt de toegekende lening in eerste instantie voor gebruikt? Voor nu wordt de lening vooral gebruikt om het bedrijf draaiende houden terwijl wij niet uit kunnen leveren. Draaiende houden betekent dus: doorbetalen van salarissen en leveranciers, en dekken van vaste lasten zoals huur. Heb je nog tips voor andere ondernemers? Blijf focussen op cashflow. Zeker in de business van dure instrumentatie kunnen één of twee uitgestelde leveringen een dramatische impact hebben; hou dit goed in de gaten. https://www.innovationquarter.nl/wp-content/uploads/sites/9/2020/06/IQ-Blog-COL-DELMIC.jpg8811920InnovationQuarter Algemeenhttps://www.iqheadquarter.nl/iq/wp-content/uploads/sites/9/2018/04/afterscroll-site-logo.pngInnovationQuarter Algemeen2020-06-23 12:04:182020-06-23 12:06:29IQblog / COL met Sander den Hoedt, CEO van DELMIC

Delmic Frequently Asked Questions (FAQ)

  • When was Delmic founded?

    Delmic was founded in 2010.

  • Where is Delmic's headquarters?

    Delmic's headquarters is located at Kanaalweg 4, Delft.

  • What is Delmic's latest funding round?

    Delmic's latest funding round is Seed.

  • How much did Delmic raise?

    Delmic raised a total of $2.74M.

  • Who are the investors of Delmic?

    Investors of Delmic include EIC Accelerator , European Innovation Council and Horizon 2020.

  • Who are Delmic's competitors?

    Competitors of Delmic include Gatan and 2 more.

  • What products does Delmic offer?

    Delmic's products include METEOR and 3 more.

  • Who are Delmic's customers?

    Customers of Delmic include Monash Centre for Electron Microscopy, University Medical Centre Groningen, University of Utrecht and New York Structural Biology Center.

Compare Delmic to Competitors

Andelyn Biosciences Logo
Andelyn Biosciences

Andelyn Biosciences manufactures gene therapies for a variety of uses.

Genalyte Logo
Genalyte

Genalyte transforms the doctor-patient relationship by providing rapid diagnostic testing right in the doctor's office. The company's technology delivers results to physicians in minutes from just a single drop of blood, yielding better outcomes for the patient, empowering doctors to be more effective, and creating a more efficient healthcare system.

Visby Medical Logo
Visby Medical

Visby Medical is transforming the order of diagnosis and treatment for infectious diseases so clinicians can test, talk with, and treat the patient in a single visit. The company’s technology development program culminated in an instrument-free, single-use PCR platform that rapidly tests for serious infections. Originally developed for sexually transmitted infections, the Company’s FDA-cleared, CLIA-waived Sexual Health Click Test for women returns accurate results within 28 minutes. Visby Medical technology also offers the Visby Medical COVID-19 Test, and its robust pipeline includes tests for other infectious diseases. It was founded in 2015 and is based in San Jose, California.

Weavr Health Logo
Weavr Health

Weavr Health is dedicated to connecting people to health by simplifying sample collection and processing for healthcare. The Velvet device is designed so anyone, anywhere can easily collect high-quality samples without a phlebotomist. The Velvet device offers a smooth experience of blood self-collection for patients. It leverages a similar experience to traditional glucose testing, which >25% of people have experienced. Each device arrives with all that is needed to collect, package and ship quality samples to the lab for a convenient experience.

S
Sight Diagnostics

Sight Diagnostics provides affordable and accurate diagnostics in a compact platform designed for use in qualified labs in low volume settings. Its proprietary machine-vision based technology provides the capability to perform multiple tests on a single, easy-to-operate platform.

A
Accellix

Accellix develops fully automated, cost-effective, actionable cell-based analysis, 24/7 at the point of need, to a broad range of users. Its Accellix single-use cartridge analysis system provides results in less than 30 minutes, requires minimal training, and does not require users to deal with biological reagents, sample preparation, and complex data analysis.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.